𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of hairy cell leukemia by leukapheresis: When, how, and why

✍ Scribed by Dr. Lung T. Yam

Publisher
John Wiley and Sons
Year
1984
Tongue
English
Weight
228 KB
Volume
2
Category
Article
ISSN
0733-2459

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Absence of prolonged benefit of initial
Absence of prolonged benefit of initial leukapheresis therapy for hairy cell leukemia
✍ Harvey M. Golomb; Eric H. Kraut; David L. Oviatt; Edward J. Prendergast; Richard πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 English βš– 457 KB

## Abstract Four patients with the leukemic phase of hairy cell leukemia were treated with leukapheresis. Two patients failed to respond, and the other two had only transient responses; hematologic improvement lasted one month in one case and four months in the second. The patient with a four‐month

P158 Alemtuzumab for the treatment of ha
P158 Alemtuzumab for the treatment of hairy cell leukemia and atypical hairy cell leukemia variant; report of two cases
✍ B. Telek; P. Batar; L. Rejto; M. Udvardy πŸ“‚ Article πŸ“… 2007 πŸ› Elsevier Science 🌐 English βš– 51 KB

immunmodulant therapy was begun. We started steroid, cyclosporine and thalidomide therapy. The control abdominal and pelvic CT showed small residual tumor on the bladder. Repeated surgery was done, residual was taken out. At this time histological examination showed transient type between plasma cel